NCT06386315 - Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma | Biotech Hunter

Enrollment

112

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

May 30, 2026

Study Completion Date

May 30, 2026

Conditions

Indolent B-Cell Non-Hodgkin LymphomaRecurrent Indolent B-Cell Non-Hodgkin LymphomaRefractory Indolent B-Cell Non-Hodgkin LymphomaRecurrent Indolent Non-Hodgkin LymphomaRefractory Indolent Non-Hodgkin Lymphoma

Interventions

PROCEDURE

Computed Tomography

Undergo CT or PET/CT

PROCEDURE

Endoscopic Procedure

Undergo endoscopy

RADIATION

Involved-site Radiation Therapy (3 Fractions)

Undergo ISRT in 3 fractions

RADIATION

Involved-site Radiation Therapy (12 Fractions)

Undergo ISRT in 12 fractions

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (7)

54601

RECRUITING

Mayo Clinic Health System-Franciscan Healthcare, La Crosse

54701

RECRUITING

Mayo Clinic Health System-Eau Claire Clinic, Eau Claire

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

56001

RECRUITING

Mayo Clinic Health System - Mankato, Mankato

56007

RECRUITING

Mayo Clinic Health System in Albert Lea, Albert Lea

85259

RECRUITING

Mayo Clinic in Arizona, Scottsdale

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville